Skip to content
All lessons
Pulmonary · Pulmonary

Cystic Fibrosis & Bronchiectasis

A boards-focused walkthrough of cystic fibrosis and bronchiectasis: CFTR pathophysiology, the classic salty-infant and foul-sputum vignettes, sweat-chloride and HRCT diagnosis, and next-best-step management including CFTR modulators.

14 min readHigh yield

CFTR pathophysiology

Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the CFTR gene on chromosome 7, which encodes an ATP-gated chloride channel. The most common mutation, ΔF508 (deletion of Phe508, a Class II folding defect), leaves misfolded CFTR to be degraded in the ER, so the channel never reaches the cell surface.

In airway and GI epithelium, failed Cl⁻ (and secondary water) secretion — plus increased Na⁺/water reabsorption — produces thick, dehydrated secretions that plug lumina and cripple mucociliary clearance. In sweat ducts, CFTR normally reabsorbs luminal Cl⁻; the defect leaves Cl⁻ (and Na⁺) trapped in sweat, giving the hallmark salty sweat and a positive sweat chloride test. Chronic mucus stasis fuels recurrent infection — the same infection–inflammation cycle that ultimately produces bronchiectasis.

CF — systemic manifestations
  • Lungs: recurrent infections with a classic pathogen timeline — S. aureus & H. influenzae early → _Pseudomonas aeruginosa_ (mucoid) in older patients → Burkholderia cepacia (poor prognosis). Bronchiectasis, clubbing, hemoptysis.
  • Pancreas: exocrine insufficiencysteatorrhea, failure to thrive, fat-soluble vitamin (A, D, E, K) deficiency; CF-related diabetes later.
  • GI: meconium ileus in neonates (classic); distal intestinal obstruction syndrome; focal biliary cirrhosis; rectal prolapse.
  • Sinus/airway: chronic sinusitis; nasal polyps in a child = think CF.
  • Reproductive: males infertile from congenital bilateral absence of the vas deferens (CBAVD) — obstructive azoospermia with intact spermatogenesis.
  • Metabolic: salt loss → hypochloremic, hypokalemic metabolic alkalosis (pseudo-Bartter), especially in heat/dehydration.
Labeled diagram of the multi-organ health problems associated with cystic fibrosis, including lungs, pancreas, liver, intestines, and reproductive tract
CF is a multisystem disease: lungs, pancreas, GI tract, sinuses, and reproductive tract are all affected. · Wikimedia Commons — BruceBlaus. When using this image in external sources it can be cited as: Blausen.com staff (2014). "Medical gallery of Blausen Medical 2014". WikiJournal of Medicine 1 (2). DOI:10 — CC BY 3.0, via Wikimedia Commons
Vignette — the salty infant

Vignette: A 6-month-old has failure to thrive, bulky greasy foul-smelling stools, and a second episode of pneumonia. The mother notes the baby “tastes salty” when kissed. (Alternate presentation: neonate with bilious vomiting and failure to pass meconium.)

  • Diagnosis: cystic fibrosis.
  • Best confirmatory test: sweat chloride test (pilocarpine iontophoresis). Cl⁻ ≥ 60 mmol/L is diagnostic (repeat to confirm); 30–59 is intermediate → CFTR genetic testing; < 30 is normal.
  • Newborn screen: elevated immunoreactive trypsinogen (IRT) flags CF before symptoms.
  • Next step after diagnosis: start airway clearance, pancreatic enzyme replacement + ADEK vitamins, and CFTR genotyping to guide modulator therapy.
Mnemonic — ADEK and the salty kiss
  • ADEK = the fat-soluble vitamins malabsorbed in pancreatic insufficiency:
  • A → night blindness / xerophthalmia
  • D → rickets, osteopenia, hypocalcemia
  • E → neuropathy, hemolytic anemia
  • K → easy bleeding, ↑PT/INR
  • “Kiss the baby, taste the salt” — the time-honored bedside clue pointing to a positive sweat chloride test.
  • ΔF508 = a “F”olding defect (Class II) and by far the most common CF mutation — an easy anchor for exam recall.

Bronchiectasis — pathophysiology & causes

Bronchiectasis is permanent, irreversible dilation of bronchi from destruction of the airway's elastic and muscular walls. A self-perpetuating vicious cycle — infection → neutrophilic inflammation (elastase, proteases) → structural airway damage → impaired clearance → more infection — drives progression.

Board-favorite causes:

  • Cystic fibrosis — leading cause in children/young adults (developed countries); classically upper-lobe predominant.
  • Primary ciliary dyskinesia / Kartagener — dynein-arm defect → situs inversus + chronic sinusitis + bronchiectasis (+ infertility).
  • ABPA — hypersensitivity to Aspergillus in asthma/CF: central bronchiectasis, markedly ↑ IgE, eosinophilia, fleeting infiltrates.
  • Post-infectious — TB, pertussis, measles, necrotizing pneumonia.
  • Focal obstruction (tumor, foreign body) or immunodeficiency (hypogammaglobulinemia).
Vignette — copious foul sputum

Vignette: A 40-year-old with lifelong recurrent respiratory infections reports daily large-volume, foul-smelling purulent sputum, intermittent hemoptysis, and digital clubbing. CXR shows “tram-track” opacities.

  • Diagnosis: bronchiectasis.
  • Best/confirmatory test: high-resolution CT (HRCT) — the gold standard. Look for the “signet-ring sign” (dilated bronchus larger than its adjacent pulmonary artery), bronchial wall thickening, and loss of normal distal tapering.
  • PFTs: obstructive pattern — ↓FEV₁, ↓FEV₁/FVC, air trapping (↑RV).
  • Pattern clues: dextrocardia/situs inversus on that CXR → Kartagener; asthmatic with ↑IgE + eosinophilia → ABPA (treat with oral corticosteroids ± itraconazole).
Axial chest CT showing dilated, thick-walled bronchi consistent with bronchiectasis
HRCT is the gold standard for bronchiectasis; a bronchus wider than its adjacent artery produces the classic signet-ring sign. · Wikimedia Commons — Mcgfowler — CC BY-SA 3.0, via Wikimedia Commons

CF vs. non-CF bronchiectasis

FeatureCystic fibrosisNon-CF bronchiectasis
InheritanceAR; CFTR (chr 7), ΔF508Usually acquired (post-infectious, obstruction, PCD)
Lobe predominanceUpper lobesVaries — ABPA central, TB upper, aspiration lower
Key organismsS. aureusPseudomonas, B. cepaciaPseudomonas, H. influenzae
DiagnosisSweat Cl⁻ ≥60, CFTR genotype, ↑IRTHRCT (signet-ring sign)
ExtrapulmonaryPancreatic insuff., CBAVD, meconium ileusDepends on cause (situs inversus in PCD)
Signature RxCFTR modulators, dornase alfa, hypertonic salineAirway clearance, treat cause, targeted antibiotics
Management — high-yield
  • Airway clearance: daily chest physiotherapy / oscillatory (“vest”) therapy.
  • Mucolytics: dornase alfa (recombinant DNase) cleaves neutrophil-derived DNA to thin mucus; inhaled hypertonic saline rehydrates secretions.
  • Antibiotics: treat exacerbations; chronic inhaled tobramycin for Pseudomonas; azithromycin (anti-inflammatory + antimicrobial).
  • Pancreatic care: enzyme replacement with meals + ADEK supplementation.
  • CFTR modulators (disease-modifying):
  • Ivacaftor — a potentiator that opens gating (Class III, e.g., G551D) channels.
  • Correctors (lumacaftor, tezacaftor, elexacaftor) rescue ΔF508 folding/trafficking; triple therapy elexacaftor/tezacaftor/ivacaftor is now standard for patients with ≥ one F508del allele.
  • Non-CF bronchiectasis: treat the underlying cause, vaccinate, and consider surgery/bronchial artery embolization for focal disease or massive hemoptysis.

Practice Pulmonary now

Board-style questions, spaced-repetition flashcards, and a Socratic AI tutor — free to start.